Topical Betaxolol for the Prevention of Retinopathy of Prematurity
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
We hypothesize that topical betaxolol will reduce the development of severe retinopathy of
prematurity.
Phase:
Phase 1
Details
Lead Sponsor:
Smith-Kettlewell Eye Research Institute
Collaborators:
Ohio State University The University of Texas Health Science Center, Houston University of Minnesota University of Minnesota - Clinical and Translational Science Institute University of Oklahoma